Published on : Jul 18, 2014
GlaxoSmithKline has confirmed firing of 30 staff members in accordance with the investigation procedures for a corruption scandal that emerged 12 years ago. These staff members are considered to be responsible for bribing and taking kickbacks from several officials right from doctors to hospitals in 2001. Those dismissed, belonged to the GSK\'s vaccines division.
The resurgence of the scandal is likely to put GSK\'s operations in China under a massive scanner in the coming future.
The U.S. and UK authorities are also a part of this investigation procedure. The British drug manufacturer said it has a \"zero tolerance\" policy for behavior that is deemed unethical. Furthermore, the company stated that suitable action was taken against those found guilty years ago.
The Chinese police have slammed a few employees and Mark Reilly, the British head of China’s GSK division with corruption.
Serious Fraud Office, Britain will also formally investigate the matter, and the U.S. authorities will investigate the extent of violations of U.S. anti-bribery laws in China by GSK.
GlaxoSmithKline plc (GSK) is a British multinational company that heralds the pharmaceutical, biologics, vaccines, and consumer healthcare segment. It is the sixth largest pharmaceutical company in the world in terms of revenue as recorded in 2013. The company, in just over 14 years has seen a tremendous rise in this career graph. GSK still continues to pay doctors who help the company gain insight into the medical field in terms of allowing them to do market research, provide scientific advisory services, and conduct life-altering clinical trials.